Mrs. Rosenqvist is a Board member of CAMP ATMP Sweden and Nordic Cell Therapy lead at Janssen (Johnson&Johnson). She has experience of leading pharma into a new way of working in Europe – new ways of collaborate in partnership with diverse stakeholders in the ”ecosystem” with the healthcare system, academy, universities authorities and the life science sector. She unleashes the power in people by having an inclusive and inspiring leadership style.
United Kingdom
Sir Andrew Dillon
Founding Chief Executive of NICE, the National Institute for Health and Care Excellence (1999 – 2020)
Visiting professor at the Institute of Global Health Innovation, Imperial College, London Independent advisor
